Expansion resistance against genotoxic E. coli: protective effects of Bifidobacterium pseudolongum in DSS-induced colitis in mice
Open Access
- 28 July 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1877186
Abstract
Introduction: Ulcerative colitis is a chronic inflammatory disease affecting the colon, and its incidence is rising worldwide. Significant alterations to the composition and function of the gut microbiota that favor the expansion of pathobionts have been shown to be involved in ulcerative colitis. One such pathobiont is Escherichia coli strains carrying the pks island ( pks + E. coli ) that contribute to mucosal injury and exacerbate inflammation. In this study, we investigated whether microbiota-targeting interventions may restrict pks + E. coli expansion and mitigate chemically induced colitis in mice. Results: In mice colonized with the murine pks + E. coli NC101 strain (EcNC101) in which acute colitis was induced by dextran sulfate sodium, oral administration of putrescine significantly reduced disease severity, histological damage, and inflammatory cytokine expression. 16S rRNA gene sequencing revealed marked shifts in gut microbiota composition following putrescine treatment, characterized by an increase in the relative abundance of Actinobacteriota and a decrease of Proteobacteria phyla. Among these, Bifidobacterium pseudolongum was associated with higher colonic acetate levels and reduced colitis severity. In EcNC101-colonized mice with colitis, B. pseudolongum administration significantly alleviated colitis by increasing acetate levels and activating peroxisome proliferator-activated receptor γ (PPAR-γ). Functional assays suggested that acetate production by B. pseudolongum contributes to competitive inhibition of EcNC101 growth. Conclusions: This study highlights the potential of microbiota-modifying interventions, particularly probiotics such as B. pseudolongum , to control pathobionts, reduce inflammation, and improve intestinal health in ulcerative colitis.Keywords
This publication has 46 references indexed in Scilit:
- Lithocholic acid ameliorates ulcerative colitis via the PXR/TLR4/NF-κB/NLRP3 signaling pathway and gut microbiota modulationCellular and Molecular Life Sciences, 2025
- Hyodeoxycholic acid relieves neuropathic pain by activating farnesoid X receptor signalingJournal of Advanced Research, 2025
- Role of polyamines in intestinal mucosal barrier functionSeminars in Immunopathology, 2025
- Insights into endogenous Bifidobacterium species in the human gut microbiota during adulthoodTrends in Microbiology, 2022
- Improvement of colonic healing and surgical recovery with perioperative supplementation of inulin and galacto-oligosaccharidesClinical Nutrition, 2021
- Ulcerative colitisThe Lancet, 2017
- Mechanisms of inflammation-driven bacterial dysbiosis in the gutMucosal Immunology, 2016
- Dextran Sulfate Sodium (DSS)‐Induced Colitis in MiceCurrent Protocols in Immunology, 2014
- Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas productionInternational Journal of Food Microbiology, 2011
- Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43Nature, 2009